189 related articles for article (PubMed ID: 28299999)
1. [Not Available].
Muheim L
Praxis (Bern 1994); 2017; 106(6):328-329. PubMed ID: 28299999
[No Abstract] [Full Text] [Related]
2. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients.
Miyaji S; Yamamoto K; Hoshino S; Yamamoto H; Sakai Y; Miyaoka H
Psychiatry Clin Neurosci; 2007 Jun; 61(3):275-82. PubMed ID: 17472596
[TBL] [Abstract][Full Text] [Related]
3. Prolonged delirium managed with risperidone.
Bourgeois JA; Hilty DM
Psychosomatics; 2005; 46(1):90-1. PubMed ID: 15765831
[No Abstract] [Full Text] [Related]
4. A double-blind trial of risperidone and haloperidol for the treatment of delirium.
Han CS; Kim YK
Psychosomatics; 2004; 45(4):297-301. PubMed ID: 15232043
[TBL] [Abstract][Full Text] [Related]
5. Delirium in hospitalized patients: Risks and benefits of antipsychotics.
Thom RP; Mock CK; Teslyar P
Cleve Clin J Med; 2017 Aug; 84(8):616-622. PubMed ID: 28806160
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotics for the treatment of delirious elders.
Ozbolt LB; Paniagua MA; Kaiser RM
J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
Boettger S; Jenewein J; Breitbart W
Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
[TBL] [Abstract][Full Text] [Related]
9. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W
Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670
[TBL] [Abstract][Full Text] [Related]
10. Comment on Nasrallah et al: lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol.
Blazer DG
Am J Geriatr Psychiatry; 2004; 12(6):658-9; author reply 659-60. PubMed ID: 15545335
[No Abstract] [Full Text] [Related]
11. Pharmacovigilance in hospice/palliative care: net effect of haloperidol for delirium.
Crawford GB; Agar M M; Quinn SJ; Phillips J; Litster C; Michael N; Doogue M; Rowett D; Currow DC
J Palliat Med; 2013 Nov; 16(11):1335-41. PubMed ID: 24138282
[TBL] [Abstract][Full Text] [Related]
12. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.
Artaloytia JF; Arango C; Lahti A; Sanz J; Pascual A; Cubero P; Prieto D; Palomo T
Am J Psychiatry; 2006 Mar; 163(3):488-93. PubMed ID: 16513871
[TBL] [Abstract][Full Text] [Related]
13. A biological basis for the sex bias of antipsychotic drugs adverse events.
Gurwitz D; Morag A; Oved K
J Am Geriatr Soc; 2013 Aug; 61(8):1437. PubMed ID: 23937507
[No Abstract] [Full Text] [Related]
14. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
Meibach RC
Neurology; 2000 Oct; 55(7):1069. PubMed ID: 11061283
[No Abstract] [Full Text] [Related]
15. Risperidone-induced neutropenia: an adverse side-effect in the palliative management of delirium in a patient with lymphoma.
Farrell H; Eastman P
BMJ Support Palliat Care; 2013 Mar; 3(1):4-5. PubMed ID: 24644317
[No Abstract] [Full Text] [Related]
16. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients.
Kim JY; Jung IK; Han C; Cho SH; Kim L; Kim SH; Lee BH; Lee HJ; Kim YK
Psychiatry Clin Neurosci; 2005 Apr; 59(2):183-8. PubMed ID: 15823165
[TBL] [Abstract][Full Text] [Related]
17. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
Kane JM; Potkin SG; Daniel DG; Buckley PF
J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotics Worsen Symptoms in Patients with Delirium Who Receive Palliative Care.
Shrikant Kulkarni N
Am Fam Physician; 2017 Mar; 95(6):Online. PubMed ID: 28318205
[No Abstract] [Full Text] [Related]
19. Use of risperidone in delirium: case reports.
Sipahimalani A; Masand PS
Ann Clin Psychiatry; 1997 Jun; 9(2):105-7. PubMed ID: 9242897
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
Shim JC; Choe BM; Kim JG; Jae YM; Kim HC; Kim SG; Oh MK; Kelly DL; Conley RR
J Clin Psychopharmacol; 2007 Aug; 27(4):400-1. PubMed ID: 17632229
[No Abstract] [Full Text] [Related]
[Next] [New Search]
